Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting
NCT02478047 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2015-06-23
Summary
The purpose of this study is to clarify whether distal-proximal point association is more effective than partial match point association by electro-acupuncture in the management of chemotherapy-induced nausea and vomiting .
Conditions
- Chemotherapy-induced Nausea and Vomiting
Interventions
- DRUG
-
only antiemetic (Ramosetron, Tropisetron and dexamethasone)
The control group will receive standard antiemetic alone. Standard antiemetic for all groups is based on American Society of Clinical Oncology clinical practice guideline. 5-hydroxytryptamine-3 (5-HT3) antagonist (Ramosetron, Tropisetron) and dexamethasone are supplied from the first day of chemotherapy, and lasting for 3-5 days.And plus antiemetic drug as the comparator group.
- OTHER
-
Matching points ST36+CV12 plus antiemetic drug
Choose both Zusanli(ST36) and Zhongwan point(CV12). Manipulating until achieving a "de Qi" sensation, then the needles are connected through a electro-acupuncture apparatus, the positive poles are linked to the needle, and the reference poles are located near the acupoint about 1cm with a paster. Frequency 10Hz,the intensity of stimulation is adjusted according to the patient's tolerance, and the electric current is less than 10mA. The operation lasts for 30 min. The treatment is scheduled to occur within 30min-60min before chemotherapy infusion for 4 days.And plus antiemetic drug as the comparator group.
- OTHER
-
Matching points PC6+CV12 plus antiemetic drug
Choose both Neiguan(PC6) and Zhongwan point(CV12). Manipulating until achieving a "de Qi" sensation, then the needles are connected through a electro-acupuncture apparatus, the positive poles are linked to the needle, and the reference poles are located near the acupoint about 1cm with a paster. Frequency 10Hz,the intensity of stimulation is adjusted according to the patient's tolerance, and the electric current is less than 10mA. The operation lasts for 30 min. The treatment is scheduled to occur within 30min-60min before chemotherapy infusion for 4 days.And plus antiemetic drug as the comparator group.
- OTHER
-
Matching points CV13+CV12 plus antiemetic drug
Choose both Shangwan(CV13) and Zhongwan point(CV12). Manipulating until achieving a "de Qi" sensation, then the needles are connected through a electro-acupuncture apparatus, the positive poles are linked to the needle, and the reference poles are located near the acupoint about 1cm with a paster. Frequency 10Hz,the intensity of stimulation is adjusted according to the patient's tolerance, and the electric current is less than 10mA. The operation lasts for 30 min. The treatment is scheduled to occur within 30min-60min before chemotherapy infusion for 4 days.And plus antiemetic drug as the comparator group.
Sponsors & Collaborators
-
National Basic Research Program, China
collaborator OTHER -
Tianjin University of Traditional Chinese Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2016-06-30
- Completion
- 2016-09-30
Countries
- China
Study Locations
More Related Trials
-
The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting
NCT02369107 ·Status: UNKNOWN ·Phase: NA
-
Acupuncture for Chemical Therapy Induced Nausea and Vomiting
NCT02842307 ·Status: COMPLETED ·Phase: NA
-
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
NCT00003817 ·Status: COMPLETED ·Phase: PHASE2
-
Is Acupuncture Able to Reduce Nausea and Vomiting in the Terminal Ill Patient
NCT04378998 ·Status: COMPLETED ·Phase: NA
-
Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT02767791 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Acupuncture and Doxylamine/Pyridoxine for Moderate to Severe Nausea and Vomiting in Pregnancy
NCT04401384 ·Status: COMPLETED ·Phase: PHASE3
-
Thumbtack Needle in the Treatment of NVP
NCT06566274 ·Status: RECRUITING ·Phase: NA
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline
NCT03740672 ·Status: UNKNOWN
-
Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy
NCT06371014 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Placebo in Acupuncture
NCT01054495 ·Status: UNKNOWN ·Phase: PHASE2
-
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NCT06769165 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Three Antiemetics in Preventing Nausea and Vomiting
NCT05533281 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics
NCT06390787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Using Interactive Mobile Application for the Management of Chemotherapy- Induced Nausea and Vomiting in Children
NCT04693832 ·Status: COMPLETED ·Phase: NA
-
Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
NCT00005994 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Laserpuncture and Standard Antiemetic on RINVR Scores in Adolescent Patients Undergoing Chemotherapy
NCT06121414 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
NCT02357420 ·Status: COMPLETED ·Phase: PHASE2
-
Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department
NCT02985840 ·Status: TERMINATED ·Phase: PHASE4
-
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
NCT01510379 ·Status: COMPLETED ·Phase: NA
-
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles
NCT06282211 ·Status: RECRUITING ·Phase: PHASE3
-
Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
NCT01556932 ·Status: COMPLETED ·Phase: NA
-
Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients
NCT03383315 ·Status: COMPLETED ·Phase: PHASE2
-
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT05319860 ·Status: COMPLETED ·Phase: PHASE2
-
Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response
NCT03675321 ·Status: COMPLETED ·Phase: NA